Table 7.
Interaction analysis of miRSNPs in GI cancers.
| Factors | Bal. Acc. CV training | Bal. Acc. CV testing | CV consistency | OR | CI | p Value |
|---|---|---|---|---|---|---|
| rs11614913 | 0.5537 | 0.4681 | 6/10 | 1.48 | 0.99–2.36 | 0.0586 |
| rs11614913, rs2910164 | 0.5918 | 0.4842 | 5/10 | 2.3 | 1.44–63.67 | 0.0004 |
| rs11614913, rs2292832, rs2910164 | 0.6415 | 0.4719 | 3/10 | 3 | 1.9–4.40 | <0.0001 |
| rs2292832, rs629367, rs6505162, rs928508 | 0.7036 | 0.5811 | 7/10 | 5.39 | 3.45–8.40 | <0.0001 |
| rs11134527, rs2292832, rs6505162, rs928508, rs895819 | 0.7865 | 0.4744 | 4/10 | 12.66 | 7.63–21.02 | <0.0001 |
CV; Cross validation, Bal; Balanced, Acc; Accuracy, OR; Odds Ratio, CI; Class interval. Significant p values are bold.